We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
American Well (AMWL) Moves 9.4% Higher: Will This Strength Last?
Read MoreHide Full Article
American Well Corporation (AMWL - Free Report) shares ended the last trading session 9.4% higher at $9.19. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.2% loss over the past four weeks.
American Well advanced amid continued investor optimism after its recent quarterly results highlighted improving margins and cost discipline.
This company is expected to post quarterly loss of $0.60 per share in its upcoming report, which represents a year-over-year change of +51.6%. Revenues are expected to be $50.13 million, down 29.3% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For American Well, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AMWL going forward to see if this recent jump can turn into more strength down the road.
American Well is part of the Zacks Medical Info Systems industry. 10x Genomics (TXG - Free Report) , another stock in the same industry, closed the last trading session 2.9% higher at $36.75. TXG has returned 27.7% in the past month.
10x Genomics' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.23. Compared to the company's year-ago EPS, this represents a change of -182.1%. 10x Genomics currently boasts a Zacks Rank of #3 (Hold).
View the Zacks #1 Rank List
Image: Bigstock
American Well (AMWL) Moves 9.4% Higher: Will This Strength Last?
American Well Corporation (AMWL - Free Report) shares ended the last trading session 9.4% higher at $9.19. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.2% loss over the past four weeks.
American Well advanced amid continued investor optimism after its recent quarterly results highlighted improving margins and cost discipline.
This company is expected to post quarterly loss of $0.60 per share in its upcoming report, which represents a year-over-year change of +51.6%. Revenues are expected to be $50.13 million, down 29.3% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For American Well, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on AMWL going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
American Well is part of the Zacks Medical Info Systems industry. 10x Genomics (TXG - Free Report) , another stock in the same industry, closed the last trading session 2.9% higher at $36.75. TXG has returned 27.7% in the past month.
10x Genomics' consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.23. Compared to the company's year-ago EPS, this represents a change of -182.1%. 10x Genomics currently boasts a Zacks Rank of #3 (Hold).